Heterogeneous copper concentrations in cancerous human prostate tissues.

about

Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.Targeting copper in cancer therapy: 'Copper That Cancer'.

P2860

Q37392908-BAB27D51-9CF0-41A3-AA21-37FED72F9653 Q38575035-6FF996D1-9709-44B2-B7AF-0A7F20A1FCE7

P2860

Heterogeneous copper concentrations in cancerous human prostate tissues.

Item

http://www.wikidata.org/entity/Q41716252

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Heterogeneous copper concentrations in cancerous human prostate tissues.

@en

type

Item

label

Heterogeneous copper concentrations in cancerous human prostate tissues.

@en

prefLabel

Heterogeneous copper concentrations in cancerous human prostate tissues.

@en

P1476

Heterogeneous copper concentrations in cancerous human prostate tissues.

@en

P2093

Delphine Denoyer

http://www.w3.org/2001/XMLSchema#string

Michael A Cater

http://www.w3.org/2001/XMLSchema#string

Peter M Meggyesy

http://www.w3.org/2001/XMLSchema#string

Sharnel A S Clatworthy

http://www.w3.org/2001/XMLSchema#string

Shashank Masaldan

http://www.w3.org/2001/XMLSchema#string

P2860

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.

Elevated copper and oxidative stress in cancer cells as a target for cancer treatment.

Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer.

Breaking through a roadblock in prostate cancer research: an update on human model systems.

Advances in copper complexes as anticancer agents.

Serum copper to zinc ratio: Relationship with aging and health status.

Copper signaling axis as a target for prostate cancer therapeutics.

Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.

Increasing intracellular bioavailable copper selectively targets prostate cancer cells.

Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells.

P304

1510-1517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shashank Masaldan

Delphine Denoyer

P577

2015-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26012532

http://www.w3.org/2001/XMLSchema#string

Heterogeneous copper concentrations in cancerous human prostate tissues.

about

P2860

P2860

Heterogeneous copper concentrations in cancerous human prostate tissues.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698